3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
52
Leukemia, Myeloid, Acute
49
Lymphoma, Non-Hodgkin
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Lymphoma
37
Leukemia
35
Hodgkin Disease
35
Myelodysplastic Syndromes
33
Lymphoma, Mantle-Cell
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large B-Cell, Diffuse
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Burkitt Lymphoma
17
Lymphoma, Follicular
12
Hematologic Neoplasms
12
Neoplasms, Plasma Cell
11
Congenital Abnormalities
11
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Biphenotypic, Acute
9
Breast Neoplasms
9
Myeloproliferative Disorders
8
Lymphoma, Large-Cell, Immunoblastic
8
Anemia, Refractory, with Excess of Blasts
8
Recurrence
7
Leukemia, Myelomonocytic, Juvenile
7
Leukemia, Myelomonocytic, Chronic
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Graft vs Host Disease
6
Sarcoma
5
Interventions
Prednisone
112
Docetaxel
87
Leuprolide
79
enzalutamide
72
Abiraterone Acetate
67
bicalutamide
53
Goserelin
50
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
42
Radiotherapy
39
abiraterone
28
Magnetic Resonance Spectroscopy
27
Gonadotropin-Releasing Hormone
24
gallium 68 PSMA-11
23
apalutamide
22
Androgen Antagonists
22
luprolide acetate gel depot
21
sipuleucel-T
20
Radiosurgery
20
Triptorelin Pamoate
18
cabazitaxel
17
cabozantinib
16
Radiotherapy, Intensity-Modulated
16
Flutamide
16
pembrolizumab
15
radium Ra 223 dichloride
14
Prednisolone
14
Nivolumab
14
Dutasteride
14
Dexamethasone
14
Radiation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostatic Neoplasms
×
Granulocyte Colony-Stimulating Factor
×
Clear all
No trials found.